TAP Block vs Spinal Orphine for Postoperative Caesarean Section Analgetics

Sponsor
Universitas Padjadjaran (Other)
Overall Status
Completed
CT.gov ID
NCT06089200
Collaborator
(none)
44
1
2
2.1
20.9

Study Details

Study Description

Brief Summary

The goal of this randomized controlled trial is to compare the effect of TAP block vs spinal morphine for post caesarean section analgesics. The main questions it aims to answer are:

  • Which post op analgesic method works better for patients who underwent caesarean section

  • The number of additional opioid needed

Condition or Disease Intervention/Treatment Phase
  • Procedure: Transversus Abdominal Plane Block
  • Procedure: Spinal Morphine
Phase 2

Study Design

Study Type:
Interventional
Actual Enrollment :
44 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Treatment
Official Title:
Comparison of Post-operative Analgetics With Transversus Abdominis Block and Spinal Morphine for Post-Caesarean Section: A Randomised Trial Study
Actual Study Start Date :
Feb 23, 2023
Actual Primary Completion Date :
Apr 28, 2023
Actual Study Completion Date :
Apr 28, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Transversus Abdominis Plane Block

Twenty two subjects were given postoperative block administration in the transversus abdominis area on each side with ultrasonography (USG) guidance

Procedure: Transversus Abdominal Plane Block
20 cc of bupivacaine 0.2% was given to the transversus abdominis plane

Active Comparator: Spinal Morphine

Twenty two subjects were given additional morphine 100 µg intrathecally

Procedure: Spinal Morphine
100 µg was administered intrathecally preoperatively

Outcome Measures

Primary Outcome Measures

  1. Length of time the patient needed the first additional opioid analgesics [24 hours post operative]

  2. Total need for additional opioids [24 hours post operative]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Indicated for caesarean section as assessed by Obstetricians

  • ASA II

  • Consented to be included in the study

Exclusion Criteria:
  • Allergy history

  • Spinal converted to general anesthesia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hasan Sadikin General Hospital Bandung Jawa Barat Indonesia 40161

Sponsors and Collaborators

  • Universitas Padjadjaran

Investigators

  • Principal Investigator: Mohammad F Maulana, MD, Faculty of Medicine Universitas Padjadjaran Bandung
  • Study Director: Suwarman, MD, Faculty of Medicine Universitas Padjadjaran Bandung
  • Study Director: Osmond M Pison, MD, Faculty of Medicine Universitas Padjadjaran Bandung
  • Study Director: Prapanca Nugraha, MD, Faculty of Medicine Universitas Padjadjaran Bandung

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Universitas Padjadjaran
ClinicalTrials.gov Identifier:
NCT06089200
Other Study ID Numbers:
  • AN-202310.01
First Posted:
Oct 18, 2023
Last Update Posted:
Oct 18, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 18, 2023